Hemorrhagic Fevers

News Hemorrhagic Fevers

• Novel 'antisense' therapies protect primates from lethal Ebola and Marburg viruses

  New studies show that treatments targeting specific viral genes protected monkeys infected with deadly Ebola or Marburg viruses. Furthermore, the animals were protected even when therapeutics were administered one hour after exposure — suggesting the approach holds promise for treating accidental in more

• Wallabies and bats harbor 'fossil' genes from the most deadly family of human viruses

  Modern marsupials may be popular animals at the zoo and in children's books, but new findings by University at Buffalo biologists reveal that they harbor a "fossil" copy of a gene that codes for filoviruses, which cause Ebola and Marburg hemorrhagic fevers and are the most lethal viruses known to hu more

• New ways to disarm deadly South American hemorrhagic fever viruses

  New World hemorrhagic fevers are emerging infectious diseases found in South America that can cause terrible, Ebola-like symptoms. Current treatments are expensive and only partially effective. Now, Howard Hughes Medical Institute (HHMI) researchers have discovered exactly how one type of New World more

White papers Hemorrhagic Fevers

• Characterizing Environments: Recent Discoveries Enabled by Metagenomic Analysis with the Genome Sequencer FLX System

  Metagenomics is the study of genomic content in a complex mixture of microorganisms. The two primary goals of this approach are to characterize the organisms present in a sample and identify what roles each organism has within a specific environment. Metagenomics samples are found nearly everywhere, including several microenvironments within the human body, soil samples, extreme environments such as deep mines, and the various layers within the ocean. Until recently, technical and economic constraints limited the depth of analysis necessary to obtain a representative picture of microbial and viral communities, their metabolic profiles, and their adaptation dynamics. Advancements in sequencing technologies, including the introduction of massively parallel pyrosequencing with the Genome Sequencer FLX System, have enabled a tremendous groundswell of research in the field of metagenomics. Dramatic improvements in throughput and the elimination of biased cloning steps have extended the field far beyond tradition more

Publications Hemorrhagic Fevers

• Virions at the Gates: Receptors and the Host–Virus Arms Race

  by John M. Coffin All viruses need to bind to specific receptor molecules on the surface of target cells to initiate infection. Virus–receptor binding is highly specific, and this specificity determines both the species and the cell type that can be infected by a given virus. In some well-studied more

• Viral load and humoral immune response in association with disease severity in puumala hantavirus infected patients ‐ implications for treatment

  Abstract Hantaviruses are the causative agents of hemorrhagic fever with renal syndrome (HFRS) in Eurasia and hantavirus cardiopulmonary syndrome (HCPS) in the Americas. The case fatality rate varies between different hantaviruses and can be up to 40%. At present, there is no specific treatment more

• Serological characterization of dengue virus infections observed among dengue hemorrhagic fever/dengue shock syndrome cases in Upper Myanmar

  Abstract In Myanmar, dengue fever (DF)/dengue hemorrhagic fever (DHF) is one of the leading causes of morbidity and mortality among children. From Pyinmana Hospital in 2004 and Mandalay Children Hospital in 2006, 160 patients diagnosed clinically to have DHF/dengue shock syndrome (DSS) were exam more

Market studies Hemorrhagic Fevers

• Biodefense Industry - Market to Benefit from Federal Funding such as the BIO EDEP Fund to Support Security Plans

  GBI Research, the leading business intelligence provider has released its latest research report, “Biodefense Industry - Market to Benefit from Federal Funding such as the BIO EDEP Fund to Support Security Plans”. The report focuses on the key insights into the biodefense industry. The report is bui more

• Green Cross Corporation (006280) - Financial and Strategic SWOT Analysis Review

  Green Cross Corporation (Green Cross) is a pharmaceutical company that is engaged in the research, development, production and commercialization of pharmaceutical products. The company offers blood derivatives, vaccines, prescription drugs, prescription drugs and healthcare food, cosmetics and other more

• Green Cross Holdings Corporation (005250) - Financial and Strategic SWOT Analysis Review

  Green Cross Holdings Corporation (Green Cross) is a biotechnology company engaged in the development of ethical drugs in the fields of virus and bacteria. It operates in four business divisions, namely Pharmaceuticals, Healthcare, Foundation and Overseas. Green Cross is engaged in the research and d more

Websites Hemorrhagic Fevers